Literature DB >> 15886232

Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities.

Robin P Peeters1, Pieter J Wouters, Hans van Toor, Ellen Kaptein, Theo J Visser, Greet Van den Berghe.   

Abstract

INTRODUCTION AND METHODS: Critical illness is associated with reduced TSH and thyroid hormone secretion, and with changes in peripheral thyroid hormone metabolism, resulting in low serum T3 and high rT3. In 451 critically ill patients who received intensive care for more than 5 d, serum thyroid parameters were determined on d 1, 5, 15, and last day (LD). All patients had been randomized for intensive or conventional insulin treatment. Seventy-one patients died, and postmortem liver and skeletal muscle biopsies were obtained from 50 of them for analysis of deiodinase (D1-3) activities.
RESULTS: Insulin treatment did not affect thyroid parameters. On d 1, rT3 was higher and T3/rT3 was lower in nonsurvivors as compared with survivors (P = 0.001). Odds ratio for survival of the highest vs. the lowest quartile was 0.3 for rT3 and 2.9 for T3/rT3. TSH, T4, and T3 were lower in nonsurvivors from d 5 until LD (P < 0.001). TSH, T4, T3, and T3/rT3 increased over time in survivors, but decreased or remained unaltered in nonsurvivors. Liver D1 activity was positively correlated with LD serum T3/rT3 (R = 0.83, P < 0.001) and negatively correlated with rT3 (R = -0.69, P < 0.001). Both liver and skeletal muscle D3 activity were positively correlated with LD serum rT3 (R = 0.32, P = 0.02 and R = 0.31, P = 0.03).
CONCLUSION: In critically ill patients who required more than 5 d of intensive care, rT3 and T3/rT3 were already prognostic for survival on d 1. On d 5, T4, T3, but also TSH levels are higher in patients who will survive. Serum rT3 and T3/rT3 were correlated with postmortem tissue deiodinase activities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886232     DOI: 10.1210/jc.2005-0535

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  68 in total

1.  Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis?

Authors:  Stefanie Meyer; Philipp Schuetz; Melanie Wieland; Charly Nusbaumer; Beat Mueller; Mirjam Christ-Crain
Journal:  Endocrine       Date:  2011-01-06       Impact factor: 3.633

2.  Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling.

Authors:  Johannes W Dietrich; Patrick Müller; Fabian Schiedat; Markus Schlömicher; Justus Strauch; Apostolos Chatzitomaris; Harald H Klein; Andreas Mügge; Josef Köhrle; Eddy Rijntjes; Ina Lehmphul
Journal:  Eur Thyroid J       Date:  2015-05-23

3.  Hormonal status and ICU-acquired paresis in critically ill patients.

Authors:  Tarek Sharshar; Sylvie Bastuji-Garin; Bernard De Jonghe; Robert D Stevens; Andrea Polito; Virginie Maxime; Pablo Rodriguez; Charles Cerf; Hervé Outin; Philippe Touraine; Kathleen Laborde
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

Review 4.  [Limits and relevance of the laboratory diagnosis of malnutrition in the elderly].

Authors:  Alexander Lapin
Journal:  Wien Med Wochenschr       Date:  2006-03

Review 5.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

Review 6.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

7.  Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Authors:  Yves Debaveye; Björn Ellger; Liese Mebis; Theo J Visser; Veerle M Darras; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 8.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

9.  Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness.

Authors:  Liese Mebis; Yves Debaveye; Björn Ellger; Sarah Derde; Eric-Jan Ververs; Lies Langouche; Veerle M Darras; Eric Fliers; Theo J Visser; Greet Van den Berghe
Journal:  Crit Care       Date:  2009-09-11       Impact factor: 9.097

10.  Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function.

Authors:  Jaap J M Teunissen; Eric P Krenning; Frank H de Jong; Yolanda B de Rijke; Richard A Feelders; Maarten O van Aken; Wouter W de Herder; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.